Nintedanib: Patient-Friendly Guide (UK)

Nintedanib is a medicine used to treat certain serious lung diseases. This guide explains what nintedanib is, how it works, how it is taken, what to watch for, and where to find support in the United Kingdom. It is written in a patient-friendly style for online pharmacy visitors.

1) Basic product information

In the UK, nintedanib is considered a specialist medicine for eligible patients under national guidance and prescribing pathways. Availability in community settings may depend on local supply arrangements.

2) How nintedanib works (mechanism of action)

Nintedanib blocks several signalling pathways involved in fibrosis (scarring) and abnormal blood-vessel growth. In particular, it inhibits enzymes known as tyrosine kinases linked to receptors such as:

• VEGFR (vascular endothelial growth factor receptors)
• FGFR (fibroblast growth factor receptors)
• PDGFR (platelet-derived growth factor receptors)
• Other related targets that contribute to scarring and progression

By interfering with these pathways, nintedanib may help slow the decline in lung function in conditions where lung scarring progresses.

3) Pharmacokinetics: how the body absorbs and processes it

“Pharmacokinetics” describes what the body does to a drug (absorption, distribution, metabolism, and elimination). While individual response can vary, these are the key general points for nintedanib:

• Absorption: Nintedanib is absorbed after oral dosing. Food can influence the amount absorbed, which is why it is commonly taken with specific meal guidance (see below).
• Distribution: It distributes into the body and reaches the systemic circulation where it can exert its effects.
• Metabolism: The liver primarily metabolises nintedanib. Enzymes involved include mainly CYP3A4.
• Elimination: It is cleared from the body largely via metabolic routes. Kidney elimination is generally less dominant.
• Interactions: Because of liver metabolism, medicines that affect CYP3A4 may change nintedanib levels.

Your prescriber may adjust your plan based on liver health, co-medications, and tolerance. Regular monitoring (particularly liver blood tests) is common with nintedanib therapy.

4) Typical use in the UK: what nintedanib is used for

Nintedanib is used for progressive fibrosing interstitial lung disease (PF-ILD) and for idiopathic pulmonary fibrosis (IPF), where appropriate under UK guidance. It helps to slow disease progression in patients who meet clinical criteria.

Indications commonly associated with nintedanib include:

• Idiopathic pulmonary fibrosis (IPF)
• Progressive fibrosing interstitial lung diseases (PF-ILD), including some forms of interstitial lung disease where fibrosis progresses despite standard care
• Other progressive fibrosing phenotypes may be considered depending on local specialist assessment and eligibility

Because interstitial lung disease is complex, the right choice of medicine depends on your exact diagnosis, severity, imaging, lung function testing, and overall health.

5) Dosing: how nintedanib is usually taken

Dosing can vary by product strength, tolerability, and clinical factors. In practice, nintedanib is typically taken in a regular twice-daily schedule. A specialist team may also reduce the dose if side effects occur.

General dosing principles (patient-friendly overview):

• Take it at the same times each day to maintain steadier drug levels.
• Do not change your dose schedule unless advised by your healthcare team.
• If you miss a dose: take it when you remember if it is not too close to the next dose. If it is close, skip the missed dose and continue your usual schedule. (Follow the product instructions provided with your medicine.)

Your pharmacist or healthcare team can confirm the exact regimen on the label for the specific capsule strength you receive.

6) Timing and food interactions

Food can affect nintedanib absorption. Many patients are advised to take nintedanib with food to reduce gastrointestinal side effects and improve consistency of absorption.

Patient-friendly guidance:

• Take nintedanib with a meal (for example, during breakfast and dinner), if that is how your regimen is set.
• Swallow capsules whole with water; do not crush or open unless specifically instructed by your healthcare provider.
• If you have a poor appetite or nausea, speak to your healthcare team—there may be strategies to help you keep taking your medicine safely.

If you have questions about meal timing (e.g., shift work, late dinners, fasting religious observance), discuss the safest approach with your healthcare team. They can help you plan a consistent schedule.

7) Alcohol and medicine interactions

Because nintedanib is metabolised by the liver, it is important to consider liver stress and overall safety. There is no single rule that fits everyone, but the following principles are commonly advised:

• Alcohol: Keep alcohol intake moderate (or avoid heavy drinking). Heavy alcohol use may increase the risk of liver problems and can worsen diarrhoea and stomach upset.
• Hydration: Nintedanib can cause diarrhoea in some people—alcohol may worsen dehydration. If you drink, take care to maintain fluids.
• Other medicines: Many drug interactions can occur, particularly with medicines that affect liver enzymes (especially CYP3A4).

Tell your healthcare team about all products you take, including over-the-counter medicines, herbal remedies, and supplements. This helps reduce the risk of interactions.

8) Medicines that may interact with nintedanib (important)

Nintedanib levels may rise or fall when taken with other medicines. This can affect safety (for example, higher diarrhoea risk) or effectiveness. Interactions can be complex; always check with your pharmacist if you start, stop, or change any medicine.

Common interaction categories (examples):

• Strong CYP3A4 inhibitors (can increase nintedanib levels) such as some antifungals and certain antivirals
• Strong CYP3A4 inducers (can reduce nintedanib levels) such as some anti-seizure medicines and certain antibiotics like rifampicin
• Other medicines affecting liver function (may increase risk of liver enzyme elevations)
• Medicines associated with bleeding risk (because of effects on growth factor pathways; your team may monitor more closely)

This is not an exhaustive list. Your pharmacist can check interaction risks for your specific medicine list.

9) Safety profile: what side effects to expect

Like all medicines, nintedanib can cause side effects. Many people tolerate it after adjustments and supportive care, but some effects require prompt medical attention.

Common side effects

• Diarrhoea (often the most common). It may start within days to weeks of therapy.
• Nausea
• Vomiting
• Abdominal pain or stomach upset
• Decreased appetite
• Fatigue or weakness
• Elevated liver enzymes (detected on blood tests)

Less common but important risks

• Liver injury: symptoms can include yellowing of the skin/eyes (jaundice), dark urine, unusual itching, or persistent nausea—seek medical advice urgently if these occur.
• Bleeding: unusual bruising, nosebleeds that won’t stop, or blood in vomit/stool should be assessed promptly.
• Blood pressure changes in some patients
• Kidney-related issues may occur indirectly, especially if dehydration occurs due to diarrhoea
• Interstitial lung disease worsening: while nintedanib is used for progressive fibrosing disease, monitoring by specialists is essential

When to get urgent help

Contact urgent medical services or seek immediate help if you experience:

• Signs of a severe allergic reaction (swelling of face/lips, trouble breathing, severe rash)
• Severe or persistent diarrhoea leading to dehydration (dizziness, fainting, very low urine output)
• Vomiting blood or passing black/tarry stools
• Yellow skin or eyes, severe abdominal pain, or significantly worsening weakness

10) Practical use tips to make treatment easier

A few simple strategies can help many patients cope with common side effects such as diarrhoea and stomach upset. Always follow your healthcare team’s advice for medicines that you can take to manage side effects.

• Start with a plan for diarrhoea: keep anti-diarrhoeal medicines ready if your prescriber/pharmacist has approved them for you. Early treatment often helps prevent escalation.
• Hydration matters: drink regularly, especially during the first weeks of therapy or if diarrhoea starts. Oral rehydration solutions can be useful.
• Small, frequent meals: if nausea occurs, try smaller meals rather than large portions. Take doses with food as advised.
• Track side effects: note timing, severity, and what you ate. This can help your team adjust timing, dose, or supportive medications.
• Liver monitoring: attend blood tests on schedule. Elevated liver enzymes may require dose interruption, reduction, or stopping.
• Avoid self-starting interacting medicines: particularly herbal preparations or “new” supplements. Ask your pharmacist first.
• Keep a medication list: include prescription and over-the-counter items for quick reference during reviews.

11) Alternative options (what else may be considered)

Treatment choice depends on your specific diagnosis, disease severity, lung function trends, comorbidities, and what has been tried previously. If nintedanib is not suitable due to side effects or interactions, your specialist may consider other options.

Potential alternatives may include:

• Other antifibrotic medicines for idiopathic pulmonary fibrosis or certain PF-ILD settings (your specialist will determine eligibility)
• Supportive care that can be combined with antifibrotic approaches, such as pulmonary rehabilitation and symptom-targeted treatments
• Condition-specific therapies if the interstitial lung disease has an autoimmune or inflammatory component (for example, immunosuppressive strategies may be considered where appropriate)

Ask your specialist what alternative is appropriate for your diagnosis and why. Switching or stopping therapy should always be clinician-led.

12) Market and legal context in the United Kingdom

In the UK, medicines like nintedanib are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and are dispensed under the Medicines Act framework. Specialist prescribing and supply arrangements can vary depending on local health board and commissioning decisions.

Access and eligibility may be influenced by:

• National guidance and specialist assessment
• Local commissioning and formularies
• Eligibility criteria used by healthcare services to decide which patients benefit most

If you are buying from an online pharmacy, ensure the seller is reputable and compliant with UK pharmacy regulations. A legitimate pharmacy should provide clear information about product identification, batch details, and safe handling.

13) Recent guidance and monitoring (what patients often experience)

For nintedanib, ongoing clinical monitoring is central to safe use. This commonly includes:

• Liver blood tests (for example, ALT/AST and bilirubin) at baseline and during therapy, with more frequent checks when clinically indicated
• Assessment of diarrhoea and gastrointestinal tolerance
• General symptom reviews to detect dehydration, weight loss, or fatigue progression
• Review of concomitant medicines to minimise interaction risk

Your healthcare team may also schedule lung function tests and imaging according to your condition and treatment plan. Guidance can evolve as new evidence appears, so follow the advice from your specialist service.

14) Delivery, availability, and what to expect when ordering in the UK

Availability of specific brands and capsule strengths can vary. When ordering online, you may be asked to confirm:

• Your delivery address and availability for courier drop-off
• That you can receive the correct product strength and pack size
• Any relevant handling requirements (most capsules should be stored at room temperature unless the label states otherwise)

Typical delivery expectations:

• Dispatch times: can vary depending on stock and verification steps
• Delivery window: often provided at checkout
• Cold chain: nintedanib capsules are generally not “cold chain” products, but always follow the packaging instructions

If you require urgent supply (for example, to avoid running out), contact the pharmacy customer support team before placing your order. Many online pharmacies can advise on stock status and alternative pack options.

15) Storage and handling

Follow the instructions on the medicine packaging. In general:

• Store in a safe place away from children.
• Store at the temperature stated on the label (often room temperature).
• Keep capsules in the original packaging to protect from moisture.
• Do not use after the expiry date.

16) FAQ

How long does it take to know if nintedanib is working?

Response to antifibrotic therapy is often assessed over time using lung function tests and symptom changes. Some patients notice stabilisation rather than immediate improvement. Your specialist will set an appropriate monitoring schedule for your situation.

What should I do if I get diarrhoea?

Diarrhoea is common. Start supportive measures early: drink fluids and consider an anti-diarrhoeal approach if approved by your healthcare team. If diarrhoea is severe, persistent, or leads to signs of dehydration, contact medical services promptly.

Can I stop taking nintedanib if I feel better?

Stopping or changing treatment can allow disease progression. Decisions to stop should be made with your specialist based on your overall risk, side effects, and monitoring results.

Is nintedanib safe with other medicines?

Nintedanib can interact with medicines that affect liver enzymes (especially CYP3A4) and with some medicines that influence bleeding risk or liver health. Always provide your full medicine list to your pharmacist for interaction checks.

Should I take it with food?

Many patients are advised to take nintedanib with food to support consistent absorption and help reduce gastrointestinal side effects. Follow the instructions on your label and the advice from your healthcare team.

Can I drink alcohol while taking nintedanib?

Moderate alcohol may be acceptable for some people, but heavy drinking can increase risks (particularly liver-related risks and dehydration). If you have liver enzyme elevations or frequent diarrhoea, it’s best to avoid alcohol and ask your healthcare team for personal guidance.

What liver monitoring will I need?

Blood tests to check liver enzymes are commonly performed at baseline and at intervals during treatment, and more often if you develop symptoms or if levels rise. Attend all scheduled tests.

What if I miss a dose?

If you miss a dose, take it when you remember unless it is close to the next scheduled dose. If it is close, skip the missed dose and resume your regular schedule. For exact instructions, follow the patient information leaflet supplied with your medicine.

Are there alternatives if side effects are too difficult?

Yes—your specialist can discuss dose adjustment, supportive care for diarrhoea and nausea, or alternative treatments depending on your diagnosis and eligibility. Do not adjust dosing yourself.

How should I handle missed deliveries or running out?

Plan ahead for refills, and contact customer support if delivery is delayed. Running out unexpectedly can interrupt treatment; ask your pharmacy about reliable lead times and reserve options.

17) Key takeaways

• Nintedanib is an oral antifibrotic medicine used for certain progressive fibrosing interstitial lung diseases.
• It works by blocking signalling pathways that contribute to fibrosis and disease progression.
• Food timing is important—many patients take it with meals to reduce side effects.
• Diarrhoea is the most common side effect; early management and hydration are crucial.
• Liver monitoring is a key safety step during treatment.
• Drug interactions can be significant, particularly with liver enzyme inducers or inhibitors.
• If you have questions about ordering or availability in the UK, speak to your online pharmacy’s support team.

This webpage provides general information about nintedanib. Your healthcare team may personalise advice based on your diagnosis, other medical conditions, and your full list of medicines.